Viewing Study NCT04375956


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-02-22 @ 9:39 AM
Study NCT ID: NCT04375956
Status: UNKNOWN
Last Update Posted: 2021-12-20
First Post: 2020-04-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module